Kymera Therapeutics (KYMR) Other Non-Current Liabilities (2020 - 2023)

Kymera Therapeutics (KYMR) has 4 years of Other Non-Current Liabilities data on file, last reported at $8000.0 in Q3 2023.

• On a quarterly basis, Other Non-Current Liabilities fell 96.88% year-over-year to $8000.0 in Q3 2023; TTM through Sep 2023 was $8000.0, a 96.88% decrease from a year earlier, with the FY2022 full-year figure at $248000.0, up 275.76% from the prior year.
• Other Non-Current Liabilities for Q3 2023 stood at $8000.0, down from $230000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for KYMR reached as high as $273000.0 in Q1 2022 and fell as low as $8000.0 in Q3 2023.
• Historically, Other Non-Current Liabilities has averaged $161166.7 across 4 years, with a median of $165000.0 in 2020.
• Across the five-year window, Other Non-Current Liabilities jumped 275.76% in 2022 and slumped 96.88% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $100000.0 in 2020, then tumbled by 34.0% to $66000.0 in 2021, then soared by 275.76% to $248000.0 in 2022, then plunged by 96.77% to $8000.0 in 2023.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $8000.0 in Q3 2023, $230000.0 in Q2 2023, and $237000.0 in Q1 2023.